Work

Economic modelling to inform pricing for LMICs of immune checkpoint inhibitors in advanced PD-L1-high non-small cell lung cancer.

Year: 2025

Type: conference-abstract

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2025.43.16_suppl.1518

Authors: Giulia Segafredo, Dario Trapani, Manju Sengar, Paul Ruff, Esteban Burrone, Hannah Schirrmacher, Konstantina Politopoulou, Chrissy Bishop, Federico Cairoli

Institutions: Medicines Patent Pool, European Institute of Oncology, Tata Memorial Hospital, University of the Witwatersrand

Language: English

Topic: Health Systems, Economic Evaluations, Quality of Life

Subfield: Economics and Econometrics

Field: Economics, Econometrics and Finance

Domain: Social Sciences

SDGs: Good health and well-being, Reduced inequalities

Open Access status: closed

OpenAlex ID: W4410813115

Cites:

Cited by: 1

Related to: 10